Precision Virologics' Seed Round

Precision Virologics raised a round of funding on March 31, 2017. Investors include Oncolys BioPharma.

Precision Virologics develops targeted vaccines for emerging infectious diseases, such as the Zika virus.…

Articles about Precision Virologics' Seed Round: